Minimum clinically important difference in the positive and negative syndrome scale with data from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE)

Journal of Clinical Psychiatry

Volumn 73, Issue 4, 2012, Pages 526-532

  Hermes, Eric D A ^a   Sokoloff, Daniel ^b   Stroup, T Scott ^c   Rosenheck, Robert A ^d  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY   (United States)

^c NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^d VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL GLOBAL IMPRESSION SCALE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; HUMAN; MAJOR CLINICAL STUDY; MEASUREMENT ERROR; OUTCOME ASSESSMENT; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; PSYCHOLOGICAL RATING SCALE; SCANNING ELECTRON MICROSCOPY; SCHIZOPHRENIA; SCORING SYSTEM;

EID: 84860597394     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.11m07162     Document Type: Article

References (34)

1. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13(2):261-276. PubMed (Pubitemid 18039085)
2. Opler LA, Ramirez PM. Use of the Positive and Negative Syndrome Scale (PANSS) in Clinical Practice. J Prac. Psych. and Behav Hlth. 1998;4:157-162. (Pubitemid 128765524)
3. Fleischhacker WW, Kemmler G. The clinical relevance of percentage improvements on the PANSS score. Neuropsychopharmacology. 2007;32(11):2435-2436. doi:10.1038/sj.np.1301391 PubMed (Pubitemid 47587689)
4. Burlingame GM, Dunn TW, Chen S, et al. Selection of outcome assessment instruments for inpatients with severe and persistent mental illness. Psychiatr Serv. 2005;56(4):444-451. doi:10.176/api.ps.56.4.4 PubMed (Pubitemid 40471587)
5. Crosby RD, Kolotkin RL, Williams GR. Defining clinically meaningful change in health-related quality of life. J Clin Epidemiol. 2003;56(5):395-407. doi:10.1016/S0895-4356(03)04-1 PubMed (Pubitemid 36694091)
6. Jaeschke R, Singer J, Guyatt GH. Measurement of health status: ascertaining the minimal clinically important difference. Control Clin Trials. 1989;10(4):407-415. doi:10.1016/0197-2456(89)905-6 PubMed (Pubitemid 20025670)
7. Osoba D, Rodrigues G, Myles J, et al. Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol. 1998;16(1):139-144. PubMed (Pubitemid 28041591)
8. Lydick E, Epstein RS. Interpretation of quality of life changes. Qual Life Res. 1993;2(3):221-226. doi:10.107/BF043526 PubMed (Pubitemid 23203446)
9. Guy W. ECDEU Assessment Manual for Psychopharmacology. Rockville, MD: US Dept. of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, National Institute of Mental Health, Psychopharmacology Research Branch, Division of Extramural Research Programs; 1976.
10. Wyrwich KW, Tierney WM, Wolinsky FD. Further evidence supporting an SEM-based criterion for identifying meaningful intra-individual changes in health-related quality of life. J Clin Epidemiol. 1999;52(9):861-873. doi:10.1016/S0895-4356(9)071-2 PubMed (Pubitemid 29385600)
11. Levine SZ, Rabinowitz J, Engel R, et al. Extrapolation between measures of symptom severity and change: an examination of the PANSS and CGI. Schizophr Res. 2008;98(1-3):318-322. doi:10.1016/j.schres.207.09.06 PubMed (Pubitemid 350235891)
12. Schennach-Wolff R, Obermeier M, Seemüller F, et al. Does clinical judgment of baseline severity and changes in psychopathology depend on the patient population? results of a CGI and PANSS linking analysis in a naturalistic study. J Clin Psychopharmacol. 2010;30(6):726-731. doi:10.1097/JCP.0b013e3181faf39b PubMed
13. Rabinowitz J, Mehnert A, Eerdekens M. To what extent do the PANSS and CGI-S overlap? J Clin Psychopharmacol. 2006;26(3):303-307. doi:10.1097/01.jcp. 0218407.10362.6e PubMed (Pubitemid 43804622)
14. Leucht S, Kane JM, Kissling W, et al. What does the PANSS mean? Schizophr Res. 2005;79(2-3):231-238. doi:10.1016/j.schres.205.04.08 PubMed (Pubitemid 41457263)
15. Cramer J, Rosenheck R, Xu W, et al Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia. Detecting improvement in quality of life and symptomatology in schizophrenia. Schizophr Bull. 2001;27(2):227-234. PubMed (Pubitemid 33644298)
16. Stroup TS, McEvoy JP, Swartz MS, et al. The national institute of mental health clinical antipsychotic trials of intervention effectiveness (CATIE) project: schizophrenia trial design and protocol development. Schizophr Bull. 2003;29(1):15-31. PubMed (Pubitemid 36871054)
17. Lieberman JA, Stroup TS, McEvoy JP, et al Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med. 2005;353(12):1209-1223. doi:10.1056/NEJMoa05168 PubMed (Pubitemid 41345943)
18. Swartz MS, Perkins DO, Stroup TS, et al. Assessing clinical and functional outcomes in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial. Schizophr Bull. 2003;29(1):33-43. PubMed (Pubitemid 36871055)
19. Kolen MJ, Brennan RL. Test Equating. Methods and Practices. New York, NY: Springer; 1995.
20. Linn RL. Linking results of distinct assessments. Appl Meas Educ. 1993; 6(1):83-102. doi:10.1207/s15324818ame0601-5
21. Albano A. Equate: Statistical Methods for Test Score Equating. R package version 1.1-2; 2011. http://cran.r-project.org/web/packages/equate/index.html. Accessed January 10, 2012.
22. R Development Core Team. R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2011. http://www.R-project.org. Accessed January 10, 2012.
23. Wyrwich KW. Minimal important difference thresholds and the standard error of measurement: is there a connection? J Biopharm Stat. 2004;14(1):97-110. doi:10.1081/BIP-12028508 PubMed (Pubitemid 38294754)
24. Duru G, Fantino B. The clinical relevance of changes in the Montgomery-Asberg Depression Rating Scale using the minimum clinically important difference approach. Curr Med Res Opin. 2008;24(5):1329-1335. doi:10.185/0307908X291958 PubMed (Pubitemid 351741564)
25. McHorney CA, Tarlov AR. Individual-patient monitoring in clinical practice: are available health status surveys adequate? Qual Life Res. 1995;4(4):293-307. doi:10.107/BF0159382 PubMed
26. Eisen SV, Ranganathan G, Seal P, et al. Measuring clinically meaningful change following mental health treatment. J Behav Health Serv Res. 2007;34(3):272-289. doi:10.107/s1414-07-906-2 PubMed (Pubitemid 47305514)
27. Leucht S, Kane JM, Kissling W, et al. Clinical implications of brief psychiatric rating scale scores. Br J Psychiatry. 2005;187(4):366-371. doi:10.192/bjp.187.4.36 PubMed (Pubitemid 41442390)
28. Wolinsky FD, Wan GJ, Tierney WM. Changes in the SF-36 in 12 months in a clinical sample of disadvantaged older adults. Med Care. 1998;36(11):1589-1598. doi:10.1097/05650-19810-08 PubMed (Pubitemid 128456394)
29. Wyrwich KW, Nienaber NA, Tierney WM, et al. Linking clinical relevance and statistical significance in evaluating intra-individual changes in health-related quality of life. Med Care. 1999;37(5):469-478. doi:10.1097/05650-19050-06 PubMed
30. Jacobson NS, Follette WC, Revenstorf D. Psychotherapy outcome research: methods for reporting variability and evaluating clinical significance. Behav Ther. 1984;15(4):336-352. doi:10.1016/S05-7894(84)802-7 (Pubitemid 14034170)
31. Jacobson NS, Truax P. Clinical significance: a statistical approach to defining meaningful change in psychotherapy research. J Consult Clin Psychol. 1991;59(1):12-19. doi:10.1037/02-06X.59.1.12 PubMed
32. Leucht S, Kane JM, Etschel E, et al. Linking the PANSS, BPRS, and CGI: clinical implications. Neuropsychopharmacology. 2006;31(10):2318-2325. PubMed (Pubitemid 44413213)
33. Atkinson M, Zibin S, Chuang H. Characterizing quality of life among patients with chronic mental illness: a critical examination of the self-report methodology. Am J Psychiatry. 1997;154(1):99-105. PubMed (Pubitemid 27020200)
34. Trivedi MH, Daly EJ. Measurement-based care for refractory depression: a clinical decision support model for clinical research and practice. Drug Alcohol Depend. 2007;88(suppl 2):S61-S71. doi:10.1016/j.drugalcdep.207.01.07 PubMed (Pubitemid 46528065)